dactinomycin has been researched along with Vascular Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SALZMAN, EW; SCANNELL, JG; SKINNER, DB | 1 |
| Chang, KL; Huang, LW; Liu, HW; Pai, LS; Su, SJ | 1 |
| Baker, A; D'Antiga, L; Mieli-Vergani, G; Pritchard, J; Pryor, D | 1 |
3 other study(ies) available for dactinomycin and Vascular Diseases
| Article | Year |
|---|---|
THE CHALLENGE OF SUPERIOR VENA CAVAL OBSTRUCTION.
Topics: Adenocarcinoma; Angiography; Blood Vessels; Carcinoma; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Dactinomycin; Humans; Lymphoma; Mechlorethamine; Neoplasms; Prognosis; Superior Vena Cava Syndrome; Vascular Diseases; Vena Cava, Superior | 1965 |
Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression.
Topics: Adult; Biomarkers; Cells, Cultured; Cycloheximide; Cytokines; Dactinomycin; Dose-Response Relationship, Drug; Female; Flow Cytometry; Gene Expression Regulation; Homocysteine; Humans; Macrophage Migration-Inhibitory Factors; Male; Monocytes; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Risk Factors; RNA, Messenger; Vascular Diseases | 2005 |
Veno-occlusive disease with multi-organ involvement following actinomycin-D.
Topics: Antibiotics, Antineoplastic; Child, Preschool; Constriction, Pathologic; Dactinomycin; Humans; Infant; Kidney Neoplasms; Male; Multiple Organ Failure; Rhabdomyosarcoma; Testicular Neoplasms; Vascular Diseases; Wilms Tumor | 2001 |